During the past decade, Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika" are "B-cell Lymphoma" (1 trials), "Mantle Cell Lymphoma" (1 trials), "Myelodysplastic Syndromes" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika" in a lesser frequency.

Most popular intervention types in "Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Azacitidine" (1 trials), "Bevacizumab" (1 trials), "CHOP" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".